Treatment for maladaptive anger using Cognitive Behavioral Affective Therapy
Cognitive Behavioral Affective Therapy (CBAT) for Maladaptive Anger in a Community Sample: A Randomized Controlled Trial
This study is testing if a new therapy called Cognitive Behavioral Affective Therapy can help people with anger issues feel better and reduce emotional distress.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | The University of Texas at San Antonio Academic / other |
| Locations | 1 site (San Antonio, Texas) |
| Trial ID | NCT06275607 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of Cognitive Behavioral Affective Therapy (CBAT) in treating maladaptive anger, which can lead to emotional distress and aggression. Participants will be recruited from counseling clinics, support groups, and social media, and will undergo a screening process to determine eligibility. Those who qualify will be randomly assigned to either a treatment group receiving CBAT or a control group. The study aims to provide insights into how effective this therapy can be in managing anger-related issues.
Who should consider this trial
Good fit: Ideal candidates for this study are English-speaking individuals living in the United States who exhibit maladaptive anger without serious psychiatric conditions.
Not a fit: Patients currently undergoing psychological treatment or those with serious psychiatric illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve emotional regulation and reduce the risk of aggression and related health issues in patients with maladaptive anger.
How similar studies have performed: Previous studies have shown promise in using Cognitive Behavioral Affective Therapy for various psychological issues, suggesting potential success for this approach in treating maladaptive anger.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Live in the United States * Have maladaptive anger (as assessed by the STAXI-2) * Do not currently have any serious psychiatric illnesses (e.g., schizophrenia, autism, dementia, suicidal ideation) * Are not currently undergoing psychological or psychiatric treatment * Are not currently undergoing an anger treatment program * Speak English Exclusion Criteria: * Does not live in the United States * Does not have maladaptive anger, as assessed by the STAXI-2 * Has a current serious psychiatric illness (e.g., schizophrenia, autism, dementia, suicidal ideation) * Is currently undergoing psychological or psychiatric treatment * Is currently undergoing an anger treatment program * Does not speak English
Where this trial is running
San Antonio, Texas
- The University of Texas at San Antonio — San Antonio, Texas, United States (Recruiting)
Study contacts
- Study coordinator: Ephrem Fernandez, Ph.D.
- Email: ephrem.fernandez@utsa.edu
- Phone: (210) 458-5755
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.